Role of Immunohistochemistry in Fine Needle Aspiration and Core Needle Biopsy of Thyroid Nodules|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Objectives. Immunohistochemistry (IHC) has been used for the diagnosis of indeterminate results in fine needle aspiration (FNA) of thyroid nodules. However, the role of IHC in core needle biopsy (CNB) is not clear and the efficacy of testing for molecular markers following CNB has not been evaluated. The aim of this study is to compare the role of IHC staining in CNB with that in FNA when examining thyroid nodules and to compare the sensitivity and usefulness of different molecular markers.
Methods. Consecutive cases of thyroid FNA and CNB accompanied by IHC from 2004 to 2014 were included in this study with retrospective review of medical record. The rate of remaining nondiagnostic result (unsatisfactory, atypia of undetermined significance or follicular lesion of undetermined significance [AUS/FLUS]) and rate of strong expression of each molecular marker according to the diagnosis were evaluated.
Results. IHC was more frequently performed in CNB with multiple molecular markers compared to FNA (38.1% vs. 2.8%, 3 or 4 markers [Gal-3, HBME-1, CK19, and CD56] vs. 1 marker [Gal-3]). In the CNB group, 11.3% remained as AUS/FLUS after IHC, and the rate remaining nondiagnostic was significantly less than in the FNA group (42.9%). Gal-3 and CK19 showed higher specificity and expressed mainly in conventional type of papillary carcinoma and HBME-1 showed higher sensitivity for the diagnosis of carcinoma with expression in both conventional type and follicular variant papillary thyroid carcinoma.
Conclusion. With these data, we could conclude that IHC was more effective following CNB than following FNA.

번역하기

참고문헌 (Reference)

1 Saleh HA, "Utility of immunohistochemical markers in differentiating benign from malignant follicularderived thyroid nodules" 5 : 9-, 2010

2 Trimboli P, "The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration" 12 : 61-, 2014

3 Li XY, "The interpretation of 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer" 52 (52): 309-315, 2017

4 Doddi S, "The final outcome of indeterminate cytology of thyroid nodules in a District General Hospital" 36 (36): 122-127, 2015

5 정찬권, "Pathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group" 대한병리학회 49 (49): 288-299, 2015

6 Trimboli P, "Galectin-3 and HBME-1 improve the accuracy of core biopsy in indeterminate thyroid nodules" 52 (52): 39-45, 2016

7 Fadda G, "Follicular thyroid neoplasms can be classified as low-and highrisk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology" 165 (165): 447-453, 2011

8 Kim SD, "Differences in clinical features between subcategories of"atypia/follicular lesion of undetermined significance"" 28 (28): 247-252, 2017

9 Nechifor-Boila A, "Diagnostic value of HBME-1, CD56, Galectin-3 and Cytokeratin-19 in papillary thyroid carcinomas and thyroid tumors of uncertain malignant potential" 55 (55): 49-56, 2014

10 Chiu CG, "Diagnostic utility of galectin-3 in thyroid cancer" 176 (176): 2067-2081, 2010